- First quarter 2025 reported and adjusted* operating income increased 30% and 26% compared to prior year
- First quarter 2025 reported and adjusted EPS were $3.00 and $2.97, compared with $3.23 and $2.08 in the first quarter 2024
- Improving guidance for full-year reported EPS to be in the range of $10.93 to $11.63 and adjusted EPS to be in the range of $10.90 to $11.60
WESTCHESTER, Ill., May 06, 2025 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage manufacturing industry, today reported its 2025 first quarter results.
"Our strong results demonstrate the company's continued ability to deliver sales volume and operating income growth," said Jim Zallie, president and CEO of Ingredion. "While tariff changes are creating uncertainty, we are reassured by the fact that the vast majority of our products are made locally and sold locally."
"The Texture & Healthful Solutions segment delivered a robust 34% increase in operating income, driven by strong sales volume across all geographies, and especially from our clean label solutions."
"In the Food and Industrial Ingredient businesses, both the LATAM and U.S./Canada segments also delivered strong results. Double digit operating income growth in F&II-LATAM was driven by the unexpected stability of the Argentine peso, favorable market mix and lower costs, with Mexico achieving another record quarter. The F&II-U.S./Canada segment exceeded expectations due to favorable product mix, efficient cost management, and excellent market execution. Additionally, while winter disruptions are common in our industry, winterization upgrades implemented last year provided operational benefits."
"Based upon our successful first-quarter performance, we are improving our full-year earnings forecast. We remain guided by our commitment to be preferred by our customers as we leverage the experience of our team to navigate this complex business environment with agility. Our focus on sustainable growth, disciplined cost management, and a strong balance sheet provides opportunities and optionality to create future value for shareholders."
* Reported results are in accordance with U.S. generally accepted accounting principles "GAAP." Adjusted financial measures are non-GAAP financial measures. See "II. Non-GAAP Information" in the Supplemental Financial Information that follows the Condensed Consolidated Financial Statements for a reconciliation of non-GAAP financial measures to the most directly comparable GAAP measures.
Diluted Earnings Per Share (EPS)
| 1Q24 | 1Q25 | |||||
| Reported Diluted EPS | $ | 3.23 | $ | 3.00 | ||
| Impairment charges | - | 0.08 | ||||
| Restructuring and resegmentation costs | 0.03 | 0.02 | ||||
| Net gain on sale of business | (1.09 | ) | - | |||
| Tax items and other matters | (0.09 | ) | (0.13 | ) | ||
| Adjusted Diluted EPS** | $ | 2.08 | $ | 2.97 | ||
Estimated factors affecting changes in Reported and Adjusted EPS
| 1Q25 | ||
| Total items affecting EPS** | 0.89 | |
| Total operating items | 0.61 | |
| Margin | 0.60 | |
| Volume | (0.11 | ) |
| Foreign exchange | (0.05 | ) |
| Other income | 0.17 | |
| Total non-operating items | 0.28 | |
| Financing costs | 0.10 | |
| Tax rate | 0.13 | |
| Shares outstanding | 0.05 | |
| ** Totals may not sum due to rounding | ||
Other Financial Items
- At March 31, 2025, total debt was $1,784 million, and cash, including short-term investments, was $846 million, versus $1,831 million and $1.0 billion at Dec. 31, 2024.
- In the first quarter, net financing costs were $9 million, compared to $19 million for the year-ago first quarter, driven by lower net interest expense and benefitting from favorable foreign exchange impacts.
- Reported and adjusted effective tax rates for the quarter were 25.5% and 25.4%, respectively, compared to 21.0% and 28.4% for the year-ago period. The increase in the reported effective tax rate was primarily driven by favorable tax treatment on the sale of our South Korea business during the first quarter of 2024.
- Net capital expenditures in 2025 were $92 million through March 31, 2025.
Business Review
Total Ingredion
Net Sales
| $ in millions | 2024 | FX Impact | Volume | S. Korea Volume* | Price Mix | 2025 | Change | Change excl. FX | |||||
| First Quarter | 1,882 | (40) | 43 | (24) | (48) | 1,813 | (4%) | (2%) | |||||
| * Represents loss of volume due to the sale of our South Korea business | |||||||||||||
Reported Operating Income
| $ in millions | 2024 | FX Impact | Business Drivers | Restructuring/ Impairment | Other | 2025 | Change | Change excl. FX | |||||
| First Quarter | 213 | (5) | 62 | (4) | 10 | 276 | 30% | 32% | |||||
Adjusted Operating Income
| $ in millions | 2024 | FX Impact | Business Drivers | 2025 | Change | Change excl. FX | |||
| First Quarter | 216 | (5) | 62 | 273 | 26% | 29% | |||
Net Sales
- First quarter net sales decreased 4%. The decrease was driven by price mix primarily from lower raw material costs, foreign exchange impacts and the impact of the sale of our South Korea business in the first quarter of 2024, partially offset by T&HS volume increases.
Operating Income
- First quarter reported and adjusted operating income were $276 million and $273 million respectively. The difference in reported versus adjusted operating income was primarily attributable to insurance recoveries and a favorable judgment related to certain indirect taxes in Brazil, partially offset by impairment charges related to certain equity investments. Excluding foreign exchange impacts, reported operating income was up 32% and adjusted operating income was up 29% from a year ago.
Texture & Healthful Solutions
Net Sales
| $ in millions | 2024 | FX Impact | Volume | Price Mix | 2025 | Change | Change excl. FX |
| First Quarter | 597 | (3) | 40 | (32) | 602 | 1% | 1% |
Segment Operating Income
| $ in millions | 2024 | FX Impact | Business Drivers | 2025 | Change | Change excl. FX | ||
| First Quarter | 74 | - | 25 | 99 | 34% | 34% | ||
- First quarter operating income for Texture & Healthful Solutions was $99 million, an increase of $25 million from a year ago, driven by lower raw material and input costs and increased volumes, partially offset by unfavorable price mix.
Food & Industrial Ingredients-LATAM
Net Sales
| $ in millions | 2024 | FX Impact | Volume | Price Mix | 2025 | Change | Change excl. FX | |||||
| First Quarter | 616 | (28) | (10) | (5) | 573 | (7%) | (2%) | |||||
Segment Operating Income
| $ in millions | 2024 | FX Impact | Business Drivers | Argentina JV | 2025 | Change | Change excl. FX | |||
| First Quarter | 101 | (3) | 10 | 19 | 127 | 26% | 29% | |||
- First quarter operating income for Food & Industrial Ingredients-LATAM was $127 million, an increase of $26 million. The quarter's results benefited from the lapping of the devaluation of the Argentine peso on prior year results of our Argentina joint venture. Excluding the joint venture's results, segment operating income increased due to lower raw material costs that were partially offset by lower volumes. Excluding foreign exchange impacts, segment operating income was up 29%.
Food & Industrial Ingredients-U.S./Canada
Net Sales
| $ in millions | 2024 | FX Impact | Volume | Price Mix | 2025 | Change | Change excl. FX | ||||
| First Quarter | 541 | (6) | - | (15) | 520 | (4%) | (3%) | ||||
Segment Operating Income
| $ in millions | 2024 | FX Impact | Business Drivers | 2025 | Change | Change excl. FX | |||
| First Quarter | 87 | (2) | 7 | 92 | 6% | 8% | |||
- First quarter operating income for Food & Industrial Ingredients-U.S./Canada was $92 million, an increase of $5 million from a year ago. The increase was driven by lower raw material costs and improved product mix. Excluding foreign exchange impacts, segment operating income was up 8%.
All Other**
Net Sales
| $ in millions | 2024 | FX Impact | Volume | S. Korea Volume* | Price Mix | 2025 | Change | Change excl. FX | ||||
| First Quarter | 128 | (3) | 13 | (24) | 4 | 118 | (8%) | (5%) | ||||
| * Represents loss of volume due to the sale of our South Korea business | ||||||||||||
Segment Operating Income (loss)
| $ in millions | 2024 | FX Impact | Business Drivers | 2025 | Change | Change excl. FX |
| First Quarter | (4) | - | 4 | 0 | nm | nm |
- First quarter operating income (loss) for All Other improved $4 million from the prior year, primarily driven by improvements in our plant-based protein business.
** All Other consists of the businesses of multiple operating segments that are not individually or collectively classified as reportable segments. Net sales from All Other are generated primarily by sweetener and starch sales by our Pakistan business, sales of stevia and other ingredients from our PureCircle and Sugar Reduction businesses, and pea protein ingredients from our Protein Fortification business.
Dividends and Share Repurchases
In the first quarter, the Company paid $52 million in dividends to shareholders. On March 12, 2025, the Company declared a quarterly dividend of $0.80 per share that was paid on April 22, 2025. During the quarter, the Company repurchased $55 million shares of common stock.
Updated Full-Year 2025 Outlook
The Company expects its full-year 2025 reported EPS to be in the range of $10.93 to $11.63 and adjusted EPS to be in the range of $10.90 to $11.60.
This guidance reflects tariff levels in effect as of the end of April 2025 and does not consider future changes in tariffs or trade restrictions. In addition, this guidance excludes any acquisition-related integration and restructuring costs, as well as any potential impairment costs.
The Company expects full-year 2025 net sales to be up low single-digits, reflecting greater volume demand, partially offset by price mix and foreign exchange impacts. Reported operating income is expected to be up high teens as we lap prior-year impairment charges, and adjusted operating income is expected to be up mid-single-digits for full-year 2025.
The 2025 full-year outlook further assumes the following: Texture and Healthful Solutions operating income is expected to be up mid-single-digits to high single-digits, driven by sales volume growth; Food & Industrial Ingredients-LATAM operating income is expected to be up mid-single-digits; Food & Industrial Ingredients-US/CAN operating income is expected to be flat to down low single-digits; and All Other operating income is anticipated to approach breakeven profitability.
Corporate costs for full-year 2025 are expected to be up mid-single-digits to high single-digits.
For full-year 2025, the Company expects both a reported and adjusted effective tax rate of 26.0% to 27.5%.
Cash from operations for full-year 2025 is expected to be in the range of $825 million to $950 million, which reflects a return to investing in working capital balances based upon expected growth in net sales. Capital expenditures for the full year are expected to be approximately $400 to $450 million.
For the second quarter of 2025, the Company expects net sales to be flat to up low single-digits compared to the same quarter last year, with operating income expected to be flat to down low single-digits.
Conference Call and Webcast Details
Ingredion will host a conference call on Tuesday, May 6, 2025, at 8 a.m. CT/ 9 a.m. ET, hosted by Jim Zallie, president and chief executive officer, and James Gray, executive vice president and chief financial officer. The call will be webcast in real-time and can be accessed at https://ir.ingredionincorporated.com/events-and-presentations. A presentation containing additional financial and operating information will be accessible through the Company's website and available to download a few hours before the start of the call. A replay will be available for a limited time at https://ir.ingredionincorporated.com/financial-information/quarterly-results.
About the Company
Ingredion Incorporatedfor more information and the latest Company news.
Forward-Looking Statements
This news release contains or may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Ingredion intends these forward-looking statements to be covered by the safe harbor provisions for such statements.
Forward-looking statements include, among others, any statements regarding our expectations for second quarter 2025 net sales and operating income, full-year 2025 reported and adjusted earnings per share, net sales, reported and adjusted operating income, segment operating income, corporate costs, reported and adjusted effective tax rate, cash from operations, and capital expenditures, and any other statements regarding our prospects and our future operations, financial condition, volumes, cash flows, expenses or other financial items, including management's plans or strategies and objectives for any of the foregoing and any assumptions, expectations, or beliefs underlying any of the foregoing.
These statements can sometimes be identified by the use of forward-looking words such as "may," "will," "should," "anticipate," "assume," "believe," "plan," "project," "estimate," "expect," "intend," "continue," "pro forma," "forecast," "outlook," "opportunities," "potential," or other similar expressions or the negative thereof. All statements other than statements of historical facts therein are "forward-looking statements."
These statements are based on current circumstances or expectations, but are subject to certain inherent risks and uncertainties, many of which are difficult to predict and beyond our control. Although we believe our expectations reflected in these forward-looking statements are based on reasonable assumptions, investors are cautioned that no assurance can be given that our expectations will prove correct.
Actual results and developments may differ materially from the expectations expressed in or implied by these statements, based on various risks and uncertainties, including changes in consumer practices, preferences, demand and perceptions that may lessen demand for the products we make; geopolitical conflicts and actions arising from them, including the impacts on the availability and prices of raw materials and energy supplies, supply chain interruptions, and volatility in foreign exchange and interest rates; the effects of global economic conditions and the general political, economic, business, and market conditions that affect customers and consumers in the various geographic regions and countries in which we buy our raw materials or manufacture or sell our products, and the impact these factors may have on our sales volumes, the pricing of our products and our ability to collect our receivables from customers; our reliance on purchases of our products by major industries which we serve and from which we derive a significant portion of our sales, including, without limitation, the food, beverage, animal nutrition and brewing industries; the risks associated with pandemics; our ability to develop or acquire new products and services at rates or of qualities sufficient to gain market acceptance; increased competitive and/or customer pressure in the corn-refining industry and related industries, including with respect to the markets and prices for our primary products and our co-products, particularly corn oil, and the ability to pass through price increases in our key inputs; price fluctuations, supply chain disruptions, tariffs, duties and shortages affecting inputs to our procurement, production processes and delivery channels, including raw materials, energy costs and availability and cost of freight and logistics; our ability to contain costs, achieve budgets and realize expected synergies, including our ability to complete planned maintenance and investment projects on time and on budget as well as to effectively manage freight and shipping costs and hedging activities; operating difficulties at our manufacturing facilities and liabilities relating to product safety and quality; the effects of climate change and legal, regulatory, and market measures to address climate change; our ability to successfully identify and complete acquisitions, divestitures, or strategic alliances on favorable terms, as well as to successfully conduct due diligence, integrate acquired businesses or implement and maintain strategic alliances and achieve anticipated synergies with respect to such transactions; economic, political and other risks inherent in conducting operations in foreign countries and in foreign currencies; the failure to maintain satisfactory labor relations; our ability to attract, develop, motivate, and maintain good relationships with our workforce; the impact of legal and regulatory proceedings, lawsuits, claims and investigations; the impact of any impairment charges on our goodwill or long-lived assets; the impact on our business of political events, trade and international disputes, war, threats or acts of terrorism, and natural disasters; changes in government policy, law, or regulation and costs of legal compliance, including compliance with environmental regulation or the occurrence of other significant events beyond our control; changes in our tax rates or exposure to additional income tax liability; risks affecting our ability to raise funds at reasonable rates and other factors affecting our access to sufficient funds for future growth and expansion; increases in interest rates that could increase our borrowing costs; interruptions, security incidents, or failures with respect to information technology systems, processes, and sites; risks affecting the continuation of our dividend policy; and our ability to maintain effective internal control over financial reporting.
Our forward-looking statements speak only as of the date on which they are made, and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of the statement as a result of new information or future events or developments or otherwise. If we do update or correct one or more of these statements, investors and others should not conclude that we will make additional updates or corrections. For a further description of these and other risks, see "Risk Factors" and other information included in our Annual Report on Form 10-K for the year ended December 31, 2024, and our subsequent reports on Form 10-Q and Form 8-K filed with the Securities and Exchange Commission.
CONTACTS:
Investors: Noah Weiss, 773-896-5242
Media: Rick Wion, 708-209-6323
| Ingredion Incorporated Condensed Consolidated Statements of Income (Unaudited) (dollars and shares in millions, except per share data) | ||||||||||
| Three Months Ended March 31, | Change % | |||||||||
| 2025 | 2024 | |||||||||
| Net sales | $ | 1,813 | $ | 1,882 | (4%) | |||||
| Cost of sales | 1,347 | 1,465 | ||||||||
| Gross profit | 466 | 417 | 12% | |||||||
| Operating expenses | 193 | 189 | 2% | |||||||
| Other operating (income) expense, net | (10 | ) | 12 | |||||||
| Restructuring/impairment charges | 7 | 3 | ||||||||
| Operating income | 276 | 213 | 30% | |||||||
| Financing costs | 9 | 19 | ||||||||
| Net gain on sale of business | - | (82 | ) | |||||||
| Income before income taxes | 267 | 276 | (3%) | |||||||
| Provision for income taxes | 68 | 58 | ||||||||
| Net income | 199 | 218 | (9%) | |||||||
| Less: Net income attributable to non-controlling interests | 2 | 2 | ||||||||
| Net income attributable to Ingredion | $ | 197 | $ | 216 | (9%) | |||||
| Earnings per common share attributable to Ingredion common shareholders: | ||||||||||
| Weighted average common shares outstanding: | ||||||||||
| Basic | 64.5 | 65.7 | ||||||||
| Diluted | 65.6 | 66.8 | ||||||||
| Earnings per common share of Ingredion: | ||||||||||
| Basic | $ | 3.05 | $ | 3.29 | (7%) | |||||
| Diluted | 3.00 | 3.23 | (7%) | |||||||
| Ingredion Incorporated Condensed Consolidated Balance Sheets (dollars and shares in millions, except per share amounts) | ||||||||
| March 31, 2025 | December 31, 2024 | |||||||
| (Unaudited) | ||||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 837 | $ | 997 | ||||
| Short-term investments | 9 | 11 | ||||||
| Accounts receivable, net | 1,284 | 1,093 | ||||||
| Inventories | 1,172 | 1,187 | ||||||
| Prepaid expenses and assets held for sale | 63 | 67 | ||||||
| Total current assets | 3,365 | 3,355 | ||||||
| Property, plant and equipment, net | 2,289 | 2,264 | ||||||
| Intangible assets, net | 1,264 | 1,264 | ||||||
| Other non-current assets | 550 | 561 | ||||||
| Total assets | $ | 7,468 | $ | 7,444 | ||||
| Liabilities and stockholders' equity | ||||||||
| Current liabilities: | ||||||||
| Short-term borrowings | $ | 42 | $ | 44 | ||||
| Accounts payable, accrued liabilities and liabilities held for sale | 1,140 | 1,237 | ||||||
| Total current liabilities | 1,182 | 1,281 | ||||||
| Long-term debt | 1,742 | 1,787 | ||||||
| Other non-current liabilities | 496 | 486 | ||||||
| Total liabilities | 3,420 | 3,554 | ||||||
| Share-based payments subject to redemption | 42 | 60 | ||||||
| Redeemable non-controlling interests | 8 | 7 | ||||||
| Ingredion stockholders' equity: | ||||||||
| Preferred stock - authorized 25.0 shares - $0.01 par value, none issued | - | - | ||||||
| Common stock - authorized 200.0 shares - $0.01 par value, 77.8 shares issued at March 31, 2025 and December 31, 2024 | 1 | 1 | ||||||
| Additional paid-in capital | 1,158 | 1,152 | ||||||
| Less: Treasury stock (common stock: 13.5 and 13.3 shares at March 31, 2025 and December 31, 2024) at cost | (1,393 | ) | (1,355 | ) | ||||
| Accumulated other comprehensive loss | (1,025 | ) | (1,086 | ) | ||||
| Retained earnings | 5,236 | 5,092 | ||||||
| Total Ingredion stockholders' equity | 3,977 | 3,804 | ||||||
| Non-redeemable non-controlling interests | 21 | 19 | ||||||
| Total stockholders' equity | 3,998 | 3,823 | ||||||
| Total liabilities and stockholders' equity | $ | 7,468 | $ | 7,444 | ||||
| Ingredion Incorporated Condensed Consolidated Statements of Cash Flows (Unaudited) (dollars in millions) | |||||||
| Three Months Ended March 31, | |||||||
| 2025 | 2024 | ||||||
| Cash from operating activities | |||||||
| Net income | $ | 199 | $ | 218 | |||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
| Depreciation and amortization | 55 | 53 | |||||
| Mechanical stores expense | 16 | 14 | |||||
| Net gain on sale of business | - | (82 | ) | ||||
| Impairment charges | 6 | - | |||||
| Margin accounts | (3 | ) | (11 | ) | |||
| Changes in other trade working capital | (220 | ) | (25 | ) | |||
| Other | 24 | 42 | |||||
| Cash provided by operating activities | 77 | 209 | |||||
| Cash from investing activities | |||||||
| Capital expenditures and mechanical stores purchases, net | (92 | ) | (65 | ) | |||
| Proceeds from sale of business | - | 247 | |||||
| Other | 2 | (1 | ) | ||||
| Cash (used for) provided by investing activities | (90 | ) | 181 | ||||
| Cash from financing activities | |||||||
| (Payments) proceeds from borrowings, net | (48 | ) | 15 | ||||
| Commercial paper borrowings, net | - | (312 | ) | ||||
| Consideration received from sale of business | 12 | - | |||||
| Repurchases of common stock, net | (55 | ) | (1 | ) | |||
| Common stock activity for share-based compensation, net | (11 | ) | 2 | ||||
| Dividends paid, including to non-controlling interests | (52 | ) | (51 | ) | |||
| Cash used for financing activities | (154 | ) | (347 | ) | |||
| Effects of foreign exchange rate changes on cash and cash equivalents | 7 | (6 | ) | ||||
| (Decrease) increase in cash and cash equivalents | (160 | ) | 37 | ||||
| Cash and cash equivalents, beginning of period | 997 | 401 | |||||
| Cash and cash equivalents, end of period | $ | 837 | $ | 438 | |||
| Ingredion Incorporated Supplemental Financial Information (Unaudited) (dollars in millions, except for percentages) | |||||||||||
| I. Segment Information of Net Sales and Operating Income | |||||||||||
| Three Months Ended March 31, | Change | Change Excl. FX | |||||||||
| 2025 | 2024 | % | % | ||||||||
| Net Sales: | |||||||||||
| Texture & Healthful Solutions (i) | $ | 602 | $ | 597 | 1% | 1% | |||||
| Food & Industrial Ingredients - LATAM (ii) | 573 | 616 | (7%) | (2%) | |||||||
| Food & Industrial Ingredients - U.S./Canada (iii) | 520 | 541 | (4%) | (3%) | |||||||
| All Other (iv) | 118 | 128 | (8%) | (5%) | |||||||
| Total Net Sales | $ | 1,813 | $ | 1,882 | (4%) | (2%) | |||||
| Operating Income (Loss): | |||||||||||
| Texture & Healthful Solutions | $ | 99 | $ | 74 | 34% | 34% | |||||
| Food & Industrial Ingredients - LATAM | 127 | 101 | 26% | 29% | |||||||
| Food & Industrial Ingredients - U.S./Canada | 92 | 87 | 6% | 8% | |||||||
| All Other | 0 | (4 | ) | nm | nm | ||||||
| Corporate | (45 | ) | (42 | ) | (7%) | (7%) | |||||
| Sub-total | 273 | 216 | 26% | 29% | |||||||
| Restructuring and resegmentation costs | (1 | ) | (3 | ) | |||||||
| Impairment charges | (6 | ) | - | ||||||||
| Other matters | 10 | - | |||||||||
| Total Operating Income | $ | 276 | $ | 213 | 30% | 32% | |||||
| Notes | |||||||||||
| (i) Net of intersegment sales of $9 million and $15 million for the first quarter of 2025 and 2024. | |||||||||||
| (ii) Net of intersegment sales of $13 million and $10 million for the first quarter of 2025 and 2024. | |||||||||||
| (iii) Net of intersegment sales of $33 million and $26 million for the first quarter of 2025 and 2024. | |||||||||||
| (iv) Net of intersegment sales of $3 million for both the first quarter of 2025 and 2024. | |||||||||||
II. Non-GAAP Information
To supplement the consolidated financial results prepared in accordance with U.S. generally accepted accounting principles ("GAAP"), non-GAAP historical financial measures are used, which exclude certain GAAP items such as restructuring and resegmentation costs, net gain on sale of business, impairment charges, Mexico tax item, and other specified items. The term "adjusted" is generally used when referring to these non-GAAP financial measures.
Management uses non-GAAP financial measures internally for strategic decision making, forecasting future results and evaluating current performance. By disclosing non-GAAP financial measures, management intends to provide investors with a more meaningful, consistent comparison of the Company's operating results and trends for the periods presented. These non-GAAP financial measures are used in addition to and in conjunction with results presented in accordance with GAAP and reflect an additional way of viewing aspects of the Company's operations that, when viewed with its GAAP results, provide a more complete understanding of factors and trends affecting its business. Expected financial measures may not reflect certain future charges, costs and/or gains that are inherently difficult to predict and estimate due to their unknown timing, effect and/or significance. Non-GAAP adjustments are generally made to adjusted financial measures, which increases management's confidence in its ability to forecast adjusted financial measures than in its ability to forecast GAAP financial measures. These non-GAAP measures, including non-GAAP expected measures, should be considered as a supplement to, and not as a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP.
Non-GAAP financial measures are not prepared in accordance with GAAP; therefore, the Company's non-GAAP information is not necessarily comparable to similarly titled measures presented by other companies. A reconciliation of each non-GAAP financial measure to the most comparable GAAP measure is provided in the tables below.
| Ingredion Incorporated Reconciliation of GAAP Net Income attributable to Ingredion and Diluted Earnings Per Share ("EPS") to Non-GAAP Adjusted Net Income attributable to Ingredion and Adjusted Diluted EPS (Unaudited) | |||||||||||||||
| Three Months Ended March 31, 2025 | Three Months Ended March 31, 2024 | ||||||||||||||
| (in millions) | Diluted EPS | (in millions) | Diluted EPS | ||||||||||||
| Net income attributable to Ingredion | $ | 197 | $ | 3.00 | $ | 216 | $ | 3.23 | |||||||
| Adjustments: | |||||||||||||||
| Restructuring and resegmentation costs (i) | 1 | 0.02 | 2 | 0.03 | |||||||||||
| Net gain on sale of business (ii) | - | - | (73 | ) | (1.09 | ) | |||||||||
| Other matters (iii) | (7 | ) | (0.11 | ) | - | - | |||||||||
| Impairment charges (iv) | 5 | 0.08 | - | - | |||||||||||
| Tax item - Mexico (v) | (1 | ) | (0.02 | ) | (6 | ) | (0.09 | ) | |||||||
| Non-GAAP adjusted net income attributable to Ingredion | $ | 195 | $ | 2.97 | $ | 139 | $ | 2.08 | |||||||
| Net income and EPS may not sum or recalculate due to rounding. | |||||||||||||||
| Notes | |||||||||||||||
| (i) During the three months ended March 31, 2025 and 2024, there were pre-tax restructuring charges of $1 million and $3 million primarily related to the resegmentation of the business effective January 1, 2024. | |||||||||||||||
| (ii) During the three months ended March 31, 2024, there were pre-tax gains of $82 million on the sale of the business in South Korea. | |||||||||||||||
| (iii) During the three months ended March 31, 2025, there was a pre-tax benefit of $10 million primarily related to insurance recoveries and a favorable judgement related to certain indirect taxes in Brazil. | |||||||||||||||
| (iv) During the three months ended March 31, 2025, we recorded $6 million of pre-tax impairment charges, which primarily relate to other-than-temporary impairment charges related to certain equity investments. | |||||||||||||||
| (v) During the three months ended March 31, 2025 and 2024, tax benefits of $1 million and $6 million were recorded as a result of the movement of the Mexican peso against the U.S. dollar and its impact on the remeasurement of the Mexico financial statements during the periods. | |||||||||||||||
| Ingredion Incorporated Reconciliation of GAAP Operating Income to Non-GAAP Adjusted Operating Income (Unaudited) (dollars in millions, pre-tax) | |||||||
| Three Months Ended March 31, | |||||||
| 2025 | 2024 | ||||||
| Operating income | $ | 276 | $ | 213 | |||
| Adjustments: | |||||||
| Restructuring and resegmentation costs (i) | 1 | 3 | |||||
| Other matters (iii) | (10 | ) | - | ||||
| Impairment charges (iv) | 6 | - | |||||
| Non-GAAP adjusted operating income | $ | 273 | $ | 216 | |||
| For notes (i) through (iv), see notes (i) through (iv) included in the Reconciliation of GAAP Net Income attributable to Ingredion and Diluted Earnings Per Share ("EPS") to Non-GAAP Adjusted Net Income attributable to Ingredion and Adjusted Diluted EPS. | |||||||
| Ingredion Incorporated Reconciliation of GAAP Effective Income Tax Rate to Non-GAAP Adjusted Effective Income Tax Rate (Unaudited) (dollars in millions, except for percentages) | |||||||||||
| Three Months Ended March 31, 2025 | |||||||||||
| Income before Income Taxes (a) | Provision for Income Taxes (b) | Effective Income Tax Rate (b/a) | |||||||||
| As Reported | $ | 267 | $ | 68 | 25.5% | ||||||
| Adjustments: | |||||||||||
| Restructuring and resegmentation costs (i) | 1 | - | |||||||||
| Other matters (iii) | (10 | ) | (3 | ) | |||||||
| Impairment charges (iv) | 6 | 1 | |||||||||
| Tax item - Mexico (v) | - | 1 | |||||||||
| Adjusted Non-GAAP | $ | 264 | $ | 67 | 25.4% | ||||||
| Three Months Ended March 31, 2024 | |||||||||||
| Income before Income Taxes (a) | Provision for Income Taxes (b) | Effective Income Tax Rate (b/a) | |||||||||
| As Reported | $ | 276 | $ | 58 | 21.0% | ||||||
| Adjustments: | |||||||||||
| Restructuring and resegmentation costs (i) | 3 | 1 | |||||||||
| Net gain on sale of business (ii) | (82 | ) | (9 | ) | |||||||
| Tax item - Mexico (v) | - | 6 | |||||||||
| Adjusted Non-GAAP | $ | 197 | $ | 56 | 28.4% | ||||||
| For notes (i) through (v), see notes (i) through (v) included in the Reconciliation of GAAP Net Income attributable to Ingredion and Diluted Earnings Per Share ("EPS") to Non-GAAP Adjusted Net Income attributable to Ingredion and Adjusted Diluted EPS. | |||||||||||
| Ingredion Incorporated Reconciliation of Expected GAAP Diluted Earnings per Share ("GAAP EPS") to Expected Adjusted Diluted Earnings per Share ("Adjusted EPS") (Unaudited) | |||||||
| Expected EPS Range for Full-Year 2025 | |||||||
| Low End of Guidance | High End of Guidance | ||||||
| GAAP EPS | $ | 10.93 | $ | 11.63 | |||
| Adjustments: | |||||||
| Restructuring and resegmentation costs (i) | 0.02 | 0.02 | |||||
| Other matters (iii) | (0.11 | ) | (0.11 | ) | |||
| Impairment charges (iv) | 0.08 | 0.08 | |||||
| Tax item - Mexico (v) | (0.02 | ) | (0.02 | ) | |||
| Adjusted EPS | $ | 10.90 | $ | 11.60 | |||
| For notes (i) through (v), see notes (i) through (v) included in the Reconciliation of GAAP Net Income attributable to Ingredion and Diluted Earnings Per Share ("EPS") to Non-GAAP Adjusted Net Income attributable to Ingredion and Adjusted Diluted EPS. | |||||||
| Ingredion Incorporated Reconciliation of Expected GAAP Effective Income Tax Rate ("GAAP ETR") to Expected Adjusted Effective Income Tax Rate ("Adjusted ETR") (Unaudited) | |||||
| Expected Effective Income Tax Rate Range for Full-Year 2025 | |||||
| Low End of Guidance | High End of Guidance | ||||
| GAAP ETR | 26.0 | % | 27.5 | % | |
| Adjustments: | |||||
| Restructuring and resegmentation costs (i) | - | % | - | % | |
| Other matters (iii) | - | % | - | % | |
| Impairment charges (iv) | (0.1 | %) | (0.1 | %) | |
| Tax item - Mexico (v) | 0.1 | % | 0.1 | % | |
| Adjusted ETR | 26.0 | % | 27.5 | % | |
| For notes (i) through (v), see notes (i) through (v) included in the Reconciliation of GAAP Net Income attributable to Ingredion and Diluted Earnings Per Share ("EPS") to Non-GAAP Adjusted Net Income attributable to Ingredion and Adjusted Diluted EPS. | |||||
